Better cognition and academic performance are associated with Mediterranean diet adherence

The relationship between various Mediterranean-style eating patterns and cognitive and academic performance.

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally | Psychedelic Invest

Enveric Biosciences (NASDAQ: ENVB) (“Enveric”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today announced encouraging EB-003 preclinical

July 25, 2024

Doctors Perform First Partial-Face, Full-Eye Transplant

A 46-year-old military veteran is the first-ever recipient of a combined whole-eye and partial face transplant, according to clinicians at NYU Langone Health. Last May,

November 10, 2023

Novaliq’s dry eye disease therapy receives US FDA approval

Novaliq’s VEVYE (cyclosporine ophthalmic solution) 0.1% is indicated to treat the signs and symptoms of dry eye disease. Credit: megaflopp via Shutterstock.com. Biopharmaceutical company Novaliq

June 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.